RAE Argentina to the World talked to Jorge Diener, executive director at the Hadassah International Hospital in Jerusalem.
Diener headed the delegation that met with government officials about the possibility of testing the Israeli-made Brilife vaccine in Argentina.
He answered the following questions:
What are the characteristics of the Brilife vaccine? Why is Argentina being considered for testing the vaccine? If an agreement is reached...what is the calculated timeline?
What's the current COVID situation in Israel...is it totally normal, are many restrictions still in place?
Production: Silvana Avellaneda.